Alopecia Market Report for M&A, Expansion and Competitive Benchmarking (2025–2034)

 

Alopecia Market

Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.

What is the anticipated market size of the alopecia industry over the next few years?

The alopecia market size has grown steadily in recent years. It will grow from $11.05 billion in 2024 to $11.6 billion in 2025 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to growing awareness of diagnosis, increasing consumer demand, increasing number of international medical tourism centers, improved reimbursement scenarios.

The alopecia market size is expected to see steady growth in the next few years. It will grow to $13.88 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to increasing aging population, rising cosmetic concerns, increasing lifestyle factors, rising healthcare expenditure. Major trends in the forecast period include advancements in treatment options, biotechnological innovations, the growing use of artificial intelligence (AI) and machine learning (ML) in alopecia research.

Download Your Free Sample PDF:

What emerging drivers are expected to shape the future of the alopecia market?

The increase in the prevalence of hair loss is expected to propel the growth of the alopecia market going forward. Hair loss refers to the partial or complete loss of hair from areas where it usually grows. Alopecia treatment helps alopecia patients by addressing several issues with hair loss by extending hair regrowth, creating customized treatment plans, using combination therapies, and managing the physical aspect of hair loss, as these can have significant positive effects on a person's emotional well-being and quality of life. For instance, in April 2023, according to the data from the National Health Commission, a China-based executive department, over 250 million Chinese experienced hair loss, of which 42% were aged between 26 and 30. Furthermore, in February 2023, according to the Statistic Brain Research Institute, a US-based educational institute, approximately 40% of men will suffer from visible hair loss by age 35. Therefore, the increase in the prevalence of hair loss is driving the alopecia market.

class=reporthtag>Alopecia Market Driver: Surge In Proactive Measures By The Government

The surge in government initiatives is expected to propel the growth of the alopecia market going forward. Government initiatives refer to specific actions, policies, programs, or projects undertaken by government authorities at various levels to address specific issues, achieve particular goals, or promote the well-being of their constituents or society as a whole. Government initiatives can play a significant role in advancing alopecia treatment in several ways, they allocate funding for research, facilitate and expedite the approval process for new drugs and therapies, and launch public awareness campaigns to educate the public and healthcare professionals about alopecia. For instance, in June 2022, according to gov.ie (Government of Ireland), an Ireland-based minister for social protection, Heather Humphreys, introduced a new grant of $525.36 (€500) to help those with hair loss brought on by illness pay for wigs, hairpieces, or other hair replacements. This can improve the lives of those with alopecia and other disorders that result in hair loss. Therefore, the surge in government initiatives is driving the growth of the alopecia market.

What emerging segments are shaping the future landscape of the alopecia industry?

The alopecia market covered in this report is segmented –

1) By Type: Alopecia Areata, Androgenetic Alopecia, Alopecia Totalis, Traction Alopecia, Cicatricial Alopecia, Other Types

2) By Treatment: Pharmaceutical, Low Level Laser Therapy (LLLT) Devices, Hair Transplant, Regenerative Medicine, Other Treatments

3) By Gender: Male, Female

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End-User: Dermatology Clinics, Homecare Settings, Other End-Users

Subsegments:

1) By Alopecia Areata: Patchy Alopecia Areata, Persistent Patchy Alopecia Areata, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis

2) By Androgenetic Alopecia: Male Pattern Baldness, Female Pattern Hair Loss

3) By Alopecia Totalis: Complete Scalp Hair Loss

4) By Traction Alopecia: Frontal Traction Alopecia, Occipital Traction Alopecia

5) By Cicatricial Alopecia: Lichen Planopilaris, Discoid Lupus Erythematosus, Central Centrifugal Cicatricial Alopecia, Frontal Fibrosing Alopecia, Folliculitis Decalvans

6) By Other Types: Telogen Effluvium, Anagen Effluvium, Trichotillomania

View The Full Market Report:

What are the key trends shaping the alopecia market in the forecast period?

Major companies operating in the alopecia market are focused on developing innovative treatments to gain competitive advantages in the market. For instance, in June 2022, Eli Lilly and Company, a US-based pharmaceutical company, and Incyte, a US-based pharmaceutical company, unveiled their approval for luminant oral tablets by the United States Food and Drug Administration (FDA), a US-based federal agency. It is the first FDA-approved systemic treatment for treating severe alopecia areata in adults. Olumiant is also indicated for treating adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.

How are key players in the alopecia market strengthening their market position?

Major companies operating in the alopecia market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi SA, GlaxoSmithKline PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Allergan PLC, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Intertek Group PLC, Dr. Reddy's Laboratories Ltd., Cipla Limited, Almirall S.A., Aclaris Therapeutics Inc., Curallux LLC, Theradome Inc., Lexington International LLC, Histogen Inc., Apira Science Inc.

Which geographic areas are contributing significantly to the growth of the alopecia sector?

North America was the largest region in the alopecia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Can Companies Use The Alopecia Market Report to Drive Business Results?

This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:

• Time market entry or expansion using growth forecasts and CAGR trends.

• Develop competitive products by tracking key technology shifts and user preferences.

• Tailor regional strategies with in-depth geographic data and local market dynamics.

• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:

Need Customized Data On Alopecia Market?

For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments